Alzheimer's disease is characterized by more low-density erythrocytes with increased volume and enhanced β-amyloid x-40 content

Journal of Internal Medicine

Volumn 270, Issue 5, 2011, Pages 489-492

  Jaremo P ^a   Milovanovic, M ^a   Nilsson, S ^b   Buller, C ^a   Post, C ^b   Winblad, B ^c  

^a VRINNEVI HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; HEMOGLOBIN;

AGED; ALZHEIMER DISEASE; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE COUNT; ERYTHROCYTE VOLUME; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LETTER; MALE; MEAN CORPUSCULAR HEMOGLOBIN; PRIORITY JOURNAL; PROTEIN CONTENT;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CASE-CONTROL STUDIES; ERYTHROCYTES; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS;

EID: 80054011898     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2011.02388.x     Document Type: Letter

References (15)

1. Winblad B, Palmer K, Kivipelto M et al. Mild Cognitive Impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004; 256: 240-6.
2. Palmer K, Bäckman L, Winblad B, Fratiglioni L. Early symptoms and signs of cognitive deficits might not always be detectable in persons who develop Alzheimer's disease. Int Psychogeriatr 2008; 20: 252-8.
3. Ronquist G, Waldenström A. Imbalance of plasma membrane ion leak and pump relationship as a new aetiological basis of certain disease states. J Intern Med 2003; 254: 517-26.
4. Roher AE, Esh CL, Kokjohn TA et al. Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease. Alzheimers Dement 2009; 5: 18-29.
5. Bosman GJ, Bartholomeus IG, de Man AJ, van Kalmthout PJ, de Grip WJ. Erythrocyte membrane characteristics indicate abnormal cellular aging in patients with Alzheimer's disease. Neurobiol Aging 1991; 12: 13-8.
6. Chang CY, Liang HJ, Chow SY, Chen SM, Liu DZ. Hemorheological mechanisms in Alzheimer's disease. Microcirculation 2007; 14: 627-34.
7. Goodall HB, Reid AH, Findlay DJ, Hind C, Kay J, Coghill G. Irregular distortion of the erythrocytes (acanthocytes, spur cells) in senile dementia. Dis Markers 1994; 12: 23-41.
8. Mohanty JG, Eckley DM, Williamson JD, Launer LJ, Rifkind JM. Do red blood cell-beta-amyloid interactions alter oxygen delivery in Alzheimer's disease? Adv Exp Med Biol 2008; 614: 29-35.
9. Rogers J, Li R, Mastroeni D et al. Peripheral clearance of amyloid beta peptide by complement C3-dependent adherence to erythrocytes. Neurobiol Aging 2006; 27: 1733-9.
10. Engström I, Ronquist G, Pettersson L, Waldenström A. Alzheimer amyloid beta-peptides exhibit ionophore-like properties in human erythrocytes. Eur J Clin Invest 1995; 25: 471-6.
11. Jayakumar R, Kusiak JW, Chrest FJ et al. Red cell perturbations by amyloid beta-protein. Biochim Biophys Acta 2003; 1622: 20-8.
12. Järemo P. Computerised method for recording platelet density distribution. Eur J Haematol 1995; 54: 304-9.
13. Järemo P, Sandberg-Gertzen H. Platelet density and size in inflammatory bowel disease. Thromb Haemost 1996; 75: 560-1.
14. Milovanovic M, Lysen J, Ramström S, Lindahl TL, Richter A, Järemo P. Identification of low-density platelet populations with increased reactivity and elevated alpha-granule content. Thromb Res 2003; 111: 75-80.
15. Milovanovic M, Lotfi K, Lindahl TL, Hallert C, Järemo P. Platelet density subpopulations in essential thrombocythemia and healthy volunteers. Pathophysiol Haemost Thromb 2010; 37: 35-42.